Ceu Cardenal Herrera University
Elche, Alicante, 03204, Spain
NCT Number: NCT07095283
Stress urinary incontinence (SUI) is defined as the loss of the ability to hold urine after exertion, i.e., as a result of imbalances in intra-abdominal pressure, which directly affect the lower urinary tract. SUI has been shown to have a significant impact on the quality of life of those affected, impacting physical, social, and psycho-emotional aspects. Among the proposed treatments is a physiotherapeutic approach, which is offered as a less invasive and painless therapy with fewer adverse effects than pharmacological or surgical treatment. Pelvic floor muscle training (PFMT) is the most effective physiotherapeutic treatment for SUI, increasing the contractile capacity of the muscles and restoring stability throughout the pelvic diaphragm, thereby ensuring proper support of the pelvic organs. Radiofrequency (RF) therapy is currently being proposed as a therapeutic option that may offer certain advantages over those reported for photoplethysmography (PPMT). The potential benefits of RF therapy are attributed to its ability to stimulate collagen metabolism, thereby promoting tissue regeneration. Radiofrequency (RF) is a non-invasive and painless method that has the potential to yield analogous results to pelvic physical therapy (PPMT) as a standalone treatment or enhance the efficacy of PPMT when administered in conjunction with RF for stress urinary incontinence (SUI).
The objective of the present study is to analyse the effectiveness of PFMT and RF as single or combined treatments for SUI in women at Clínica Traña, a clinic specialising in the treatment of pelvic floor dysfunction in Costa Rica. Following the process of obtaining informed consent, patients will be offered a single or combined treatment of RF and/or PFMT. The strength of the pelvic floor muscles, pelvic function and the impact of pelvic dysfunctions on quality of life will be evaluated with a one-year follow-up after the conclusion of treatment.
The project possesses the facilities, equipment, and personnel necessary to ensure its viability, as well as proven clinical experience.
The scientific and technical impact of the proposed treatment protocol will be achieved by establishing an effective therapeutic strategy to address SUI. The social impact of SUI is significant, given its high prevalence and the fact that it has physical consequences as well as a negative impact on the social activities, work functions and emotions of women who suffer from it.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Elche, Alicante, 03204, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a self-administered questionnaire with four questions and a total score ranging from 0 [best] to 21 [worst] that identifies people with urinary incontinence and its impact on quality of life.
The KHQ is a self-administered instrument specifically designed to assess quality of life in women with UI. It consists of 21 items distributed across 9 dimensions: perception of overall health (1 item), impact of UI (1 item), limitations in daily activities (2 items), physical limitations (2 items), social limitations (2 items), personal relationships (3 items), emotions (3 items), sleep/energy (2 items), and severity of UI (5 items). The score range for each dimension is from 0 (lowest impact of UI and therefore best quality of life) to 100 (highest impact, worst quality of life). This questionnaire provides an overall value for the quality of life of the patient with UI (Overall Score-OS) and another specific value for each dimension on a scale with the following range: 0: Best possible quality of life - 100: Worst possible quality of life.
A two-dimensional (2D) ultrasound system with B-mode capability and cine-loop function, a 3.5 to 6 MHz curved convex probe transducer, was used for the perineal image. The examination will be performed in the dorsal lithotomy position, with the hips flexed and slightly abducted and the heels placed close to the buttocks, or in a standing position if necessary.
It allows the severity of UI to be determined based on two questions. Interpretation based on the score is classified as follows: 1-2 mild UI, 3-6 moderate UI, 8-9 severe UI, 12 very severe UI.
The strength of the Pelvic floor muscles will be evaluated digitally using functional ultrasound and classified according to the Oxford scale.
Muscular (mmHg) and static strength (seconds); Fatigability or Dynamic Endurance (% and cmH₂O)
Other names: Muscular and static strength; Fatigability or Dynamic Endurance
Time frame: Pre - post intervention; after 3,6,12 months
0 to 21 points, where higher scores indicate greater impact of incontinence
Time frame: Pre - post intervention; after 3,6,12 months
0 to 100, where 0 indicates the best quality of life and 100 the worst
Time frame: Pre - post intervention; after 3,6,12 months
degrees
Time frame: Pre - post intervention; after 3,6,12 months
degrees
Time frame: Pre - post intervention; after 3,6,12 months
degrees
Time frame: Pre - post intervention; after 3,6,12 months
defined as the ability of tissue to generate tension based on its contractile capacity, being the best of three attempts to contract, assessed using the modified OXFORD scale
Time frame: Pre - post intervention; after 3,6,12 months
The best of the three attempts is selected, graded as follows: 0 = no contraction, 1 = partial contraction, 2 = contraction of the pelvic floor muscles + contraction of related muscles, 3 = isolated contraction of the Pelvic floor muscles
Time frame: Pre - post intervention; after 3,6,12 months
the ability to maintain optimal contraction (isometric, tonic fibers) for as long as possible, measuring the seconds until fatigue sets in. ORDER: "contract and hold," taking the average of the three assessments.
Time frame: Pre - post intervention; after 3,6,12 months
maximum number of contractions in a unit of time, taking 10 seconds as the average. ORDER: "contract as many times as possible and at the highest speed," with the measurement being the average of the three assessments.
Time frame: Pre - post intervention; after 3,6,12 months
allows the contractile capacity of the pelvic floor muscles to be assessed. It scores from 0 to 5, as follows: if there is no contraction, it is scored as 0; if the contraction is very weak, it is scored as 1; if the contraction is weak, it is scored as 2; if the contraction is moderate/with tension/and sustained, it is scored as 3; if the contraction is good and maintains tension with resistance, it is scored as 4; and if the contraction is strong and maintains tension against a resistant force, it is scored as 5.
Time frame: Pre - post intervention; after 3,6,12 months
It allows the severity of UI to be determined based on two questions. Interpretation based on the score is classified as follows: 1-2 mild UI, 3-6 moderate UI, 8-9 severe UI, 12 very severe UI.
Time frame: baseline
Time frame: baseline
kg / m²
Time frame: baseline
yes/no
Time frame: baseline
yes/no
Time frame: baseline
yes/no
Time frame: baseline
Number
Time frame: baseline
yes/no
Time frame: baseline
yes/no
Time frame: baseline
yes/no
Time frame: baseline
yes/no
Time frame: baseline
yes/no
Cardenal Herrera University
Other
Second-generation Radiofrequency Application and Specific Therapeutic Exercise as a Treatment for Stress Urinary Incontinence Due to Urethral Instability. Randomised Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05390008
Aging, Behavior
Istanbul, Kayisdagi, Turkey (Türkiye)
View Trial DetailsNCT03401983
Behavior, Female Urogenital Diseases
View Trial DetailsNCT07668128
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Taipei City, Banqiao Dist, Taiwan
View Trial DetailsNCT03913845
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bethel Park, Pennsylvania, United States
View Trial Details